Topical Antibiotics and Intravitreous Injections
Information source: Stanford University
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Intravitreous; Injections
Intervention: gatifloxacin (Drug)
Phase: Phase 4
Status: Completed
Sponsored by: Stanford University Official(s) and/or principal investigator(s):
Christopher Ta, MD, Principal Investigator, Affiliation: Stanford University
Summary
Evaluation of efficacy of topical preoperative antibiotics in patients undergoing
intravitreous injections.
Clinical Details
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator)
Primary outcome: Conjunctival Bacterial FloraPositive Culture
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- intravitreous injection
Exclusion Criteria:
- antibiotic use
Locations and Contacts
Stanford, Stanford, California 94304, United States
Additional Information
Starting date: July 2008
Last updated: May 13, 2014
|
